Report cover image

South Korea Peritoneal Dialysis Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Published Jan 17, 2025
Length 187 Pages
SKU # CRRE20303345

Description

Market Overview:

The South Korea peritoneal dialysis market is projected to grow from USD 399.18 million in 2023 to USD 683.65 million by 2032, at a compound annual growth rate (CAGR) of 6.46%.

This growth is driven by the rising prevalence of chronic kidney diseases (CKD) and the increasing demand for home-based dialysis treatments. The aging population, coupled with advancements in medical technology, is leading more patients to opt for peritoneal dialysis due to its convenience and effectiveness. Additionally, government initiatives aimed at raising awareness and improving healthcare infrastructure are contributing to market expansion. The shift towards patient-centered healthcare, along with a preference for less invasive and cost-effective treatments, further supports the growth of the peritoneal dialysis market. Moreover, innovations in dialysis devices, with enhanced capabilities to improve patient comfort and treatment outcomes, and the adoption of automated systems for better monitoring, are boosting market uptake.

Market Drivers:

Increasing Prevalence of Chronic Kidney Disease (CKD):

The rising incidence of chronic kidney disease (CKD) is a key factor driving the South Korean peritoneal dialysis market. As CKD becomes more prevalent due to factors like diabetes, hypertension, and an aging population, the demand for dialysis treatments, including peritoneal dialysis, is escalating. According to the Korean National Health and Nutrition Examination Survey, the prevalence of CKD among adults aged 20 years and older stands at 8.2%. Peritoneal dialysis, known for its flexibility and suitability for home-based care, is increasingly becoming the treatment of choice for many patients.

Market Challenges:

High Cost of Treatment and Equipment:

A significant challenge for the South Korean peritoneal dialysis market is the high cost of treatment and equipment. Despite its advantages, peritoneal dialysis requires substantial financial investment, covering the costs of dialysis machines, consumables, and ongoing medical care. A study has reported that the average annual cost of peritoneal dialysis in South Korea is approximately $23,358 per patient. These expenses can be a barrier for patients, particularly those without adequate health insurance coverage. While the government offers subsidies and reimbursement options for dialysis treatments, out-of-pocket costs can still be significant, limiting the adoption of peritoneal dialysis, particularly among lower-income groups.

Segmentation:

By Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Automated Peritoneal Dialysis (APD)

By Product:

Peritoneal Dialysis Machines

Peritoneal Dialysis Solutions

Dialysis Catheters

Others

By End-User:

Hospitals

Dialysis Centers

Home Care Settings

By Geography:

Seoul Metropolitan Region

Gyeonggi Province

Busan and Ulsan Regions

Daegu Region

Key Player Analysis:

Nipro Corporation

Baxter International Inc.

Fresenius Medical Care

Terumo Corporation

Asahi Kasei Medical Co., Ltd.

Huaren Pharmaceutical Co., Ltd.

JMS Co., Ltd.

Kawasumi Laboratories Inc.

Medtronic plc

Pacific Hospital Supply Co., Ltd.

Table of Contents

187 Pages
s
CHAPTER NO. 1: INTRODUCTION
1.1.1. Report Description
Purpose of the Report
USP & Key Offerings
1.1.2. Key Benefits for Stakeholders
1.1.3. Target Audience
1.1.4. Report Scope
CHAPTER NO. 2: EXECUTIVE SUMMARY
2.1. South Korea Peritoneal Dialysis Market Snapshot
2.1.1. South Korea Peritoneal Dialysis Market, 2018 - 2032 (USD Million)
CHAPTER NO. 3: South Korea Peritoneal Dialysis Market – INDUSTRY ANALYSIS
3.1. Introduction
3.2. Market Drivers
3.3. Market Restraints
3.4. Market Opportunities
3.5. Porter’s Five Forces Analysis
CHAPTER NO. 4: ANALYSIS COMPETITIVE LANDSCAPE
4.1. Company Market Share Analysis – 2023
4.2. South Korea Peritoneal Dialysis Market Company Revenue Market Share, 2023
4.3. Company Assessment Metrics, 2023
4.4. Start-ups /SMEs Assessment Metrics, 2023
4.5. Strategic Developments
4.6. Key Players Product Matrix
CHAPTER NO. 5: PESTEL & ADJACENT MARKET ANALYSIS
CHAPTER NO. 6: South Korea Peritoneal Dialysis Market – BASED ON TYPE ANALYSIS
CHAPTER NO. 7: South Korea Peritoneal Dialysis Market – BASED ON PRODUCT ANALYSIS
CHAPTER NO. 8: South Korea Peritoneal Dialysis Market – BASED ON END-USER ANALYSIS
CHAPTER NO. 9: South Korea Peritoneal Dialysis Market – BASED ON GEOGRAPHY ANALYSIS
CHAPTER NO. 10: COMPANY PROFILES
10.1. Nipro Corporation
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. SWOT Analysis
10.1.4. Business Strategy
10.1.5. Financial Overview
10.2. Baxter International Inc.
10.3. Fresenius Medical Care
10.4. Terumo Corporation
10.5. Asahi Kasei Medical Co., Ltd.
10.6. Huaren Pharmaceutical Co., Ltd.
10.7. JMS Co., Ltd.
10.8. Kawasumi Laboratories Inc.
10.9. Medtronic plc
10.10. Pacific Hospital Supply Co., Ltd.
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.